@misc{indiciae59058de09dbb,
  title = {Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer.},
  author = {Takeo Fujii and Toshiaki Iwase and Yu Shen and Jami Fukui and Naoto T Ueno},
  year = {2025},
  doi = {10.1038/s41416-025-03197-w},
  url = {https://pubmed.ncbi.nlm.nih.gov/41109918/},
  note = {Source identifier: 41109918}
}